Keywords: gammagard, adverse, reactions, baxter, immunoglobulin, product, withdrawn
GAMMAGARD ADVERSE REACTIONS
Article | 01 August 1994
- Baxter's Gammagard immunoglobulin product, which was withdrawn in February, has been implicated in 111 possible cases of acute hepatitis C infection, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
